Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

Fintel reports that on November 4, 2024, Piper Sandler downgraded their outlook for ESSA Pharma (NasdaqCM:EPIX) from ...

In a report released today, Anna Andreeva from Piper Sandler maintained a Buy rating on Wolverine World Wide (WWW – Research Report), ...

Piper Sandler analyst Brian Mullan maintained a Hold rating on Brinker International (EAT – Research Report) today and set a price target ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

Piper Sandler analysts revised their election forecasts, giving former President Donald Trump a slight edge in the ...

Operator: Good morning. And welcome to the Piper Sandler Companies’ Third Quarter 2024 Earnings Conference Call.

The British drugmaker’s unit RBP Global Holdings Ltd. signed up with Piper Sandler Finance LLC and certain buyers for $400 ...

Good morning and welcome to the Piper Sandler Company's third quarter, 2024 earnings conference call. Today's call is being recorded and will include remarks by Piper Sandler management followed ...

Boston Beer (NYSE:SAM – Free Report) had its price objective boosted by Piper Sandler from $325.00 to $330.00 in a research ...